CHEN Shuang-gang, FAN Wei-jun, YANG Yi-fan. Comment on the TACTICS Trial: A Comparative Study of TACE Combined With Sorafenib and TACE Alone in Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 332-336. DOI: 10.12019/j.issn.1671-5144.2021.06.004
|
Citation:
|
CHEN Shuang-gang, FAN Wei-jun, YANG Yi-fan. Comment on the TACTICS Trial: A Comparative Study of TACE Combined With Sorafenib and TACE Alone in Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 332-336. DOI: 10.12019/j.issn.1671-5144.2021.06.004
|
CHEN Shuang-gang, FAN Wei-jun, YANG Yi-fan. Comment on the TACTICS Trial: A Comparative Study of TACE Combined With Sorafenib and TACE Alone in Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 332-336. DOI: 10.12019/j.issn.1671-5144.2021.06.004
|
Citation:
|
CHEN Shuang-gang, FAN Wei-jun, YANG Yi-fan. Comment on the TACTICS Trial: A Comparative Study of TACE Combined With Sorafenib and TACE Alone in Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 332-336. DOI: 10.12019/j.issn.1671-5144.2021.06.004
|
DownLoad: